Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease.
Painchart C, Brabant S, Duveau N, Nachury M, Desreumaux P, Branche J, Gérard R, Prevost CLD, Wils P, Lambin T, Boualit M, Labalette M, Pariente B.
Painchart C, et al. Among authors: gerard r.
Dig Dis Sci. 2020 May;65(5):1445-1452. doi: 10.1007/s10620-019-05865-3. Epub 2019 Oct 10.
Dig Dis Sci. 2020.
PMID: 31599389